Literature DB >> 21762758

Comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin).

Louise Carson1, George R Cathcart, Christopher J Scott, Morley D Hollenberg, Brian Walker, Howard Ceri, Brendan F Gilmore.   

Abstract

In this study we report for the first time the comprehensive inhibitor profiling of the Proteus mirabilis metalloprotease virulence factor ZapA (mirabilysin) using a 160 compound focused library of N-alpha mercaptoamide dipeptides, in order to map the S(1)(') and S(2)(') binding site preferences of this important enzyme. This study has revealed a preference for the aromatic residues tyrosine and tryptophan in P(1)(') and aliphatic residues in P(2)('). From this library, six compounds were identified which exhibited sub- to low-micromolar K(i) values. The most potent inactivator, SH-CO(2)-Y-V-NH(2) was capable of preventing ZapA-mediated hydrolysis of heat-denatured IgA, indicating that these inhibitors may be capable of protecting host proteins against ZapA during colonisation and infection.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762758     DOI: 10.1016/j.biochi.2011.06.030

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

Review 1.  Proteus mirabilis and Urinary Tract Infections.

Authors:  Jessica N Schaffer; Melanie M Pearson
Journal:  Microbiol Spectr       Date:  2015-10

2.  A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.

Authors:  Scarlet Milo; Rachel A Heylen; John Glancy; George T Williams; Bethany L Patenall; Hollie J Hathaway; Naing T Thet; Sarah L Allinson; Maisem Laabei; A Toby A Jenkins
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

3.  Comparative Screening of Digestion Tract Toxic Genes in Proteus mirabilis.

Authors:  Xiaolu Shi; Yiman Lin; Yaqun Qiu; Yinghui Li; Min Jiang; Qiongcheng Chen; Yixiang Jiang; Jianhui Yuan; Hong Cao; Qinghua Hu; Shenghe Huang
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.